Comments

Cellectar Biosciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Cellectar Biosciences (CLRB) operate in?

Cellectar Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CLRBNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q4 2024 earnings tomorrow on Thu Mar 13th before the market open

Conference call scheduled tomorrow at 8:30 AM Click to view the webcast

Cellectar Biosciences (CLRB) Forecast

News Earnings Cellectar Biosciences (CLRB) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Cellectar Biosciences Stock Price, Quotes and Forecasts | NASDAQ:CLRB | Benzinga

Explore Cellectar Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CLRB.

Open	$0.31
Close	-
Volume / Avg.	17.76K / 2.83M
Day Range	$0.31 - $0.32
52 Wk Range	0.22 - 4.17
Market Cap	$14.40M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	4.7%
Days to Cover	2.71

Recent News

Crude Oil Jumps 2%; Macy's Lowers Earnings Forecast

Avi Kapoor

Cellectar Biosciences Stock Plunges As Cancer-Focused Cancer Firm Pursues Strategic Options

Due to FDA communications, Cellectar Biosciences will explore options for development of its cancer drug. Focus on isotopes for solid tumors.

Vandana Singh

Nasdaq Surges Over 1%; US Inflation Rises In-Line With Expectations

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.31
Close	-
Volume / Avg.	17.76K / 2.83M
Day Range	$0.31 - $0.32
52 Wk Range	0.22 - 4.17
Market Cap	$14.40M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	4.7%
Days to Cover	2.71

About Cellectar Biosciences Inc

Sector

Health Care

Industry

Biotechnology

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discov...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cellectar Biosciences (CLRB) stock?

You can purchase shares of Cellectar Biosciences (NASDAQ:CLRB) through any online brokerage.

View our list of the best stock brokerages

Who are Cellectar Biosciences (CLRB) competitors?

Other companies in Cellectar Biosciences’s space includes: Eterna Therapeutics (NASDAQ:ERNA), HOOKIPA Pharma (NASDAQ:HOOK), Imunon (NASDAQ:IMNN), Evaxion Biotech (NASDAQ:EVAX) and Bolt Biotherapeutics (NASDAQ:BOLT).

What is the forecast, or price target, for Cellectar Biosciences (CLRB) stock?

Cellectar Biosciences has a consensus price target of $16.00.

What is the current price for Cellectar Biosciences (CLRB)?

The stock price for Cellectar Biosciences (NASDAQ: CLRB) is $0.3125 last updated March 12, 2025 at 9:02 AM EDT.

Does Cellectar Biosciences (CLRB) pay a dividend?

There are no upcoming dividends for Cellectar Biosciences.

When is Cellectar Biosciences (NASDAQ:CLRB) reporting earnings?

Cellectar Biosciences’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Is Cellectar Biosciences (CLRB) going to split?

There is no upcoming split for Cellectar Biosciences.

What sector and industry does Cellectar Biosciences (CLRB) operate in?

Cellectar Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.